Orlando, Fla.—Patients receiving liposomal bupivacaine (Exparel, Pacira) injection after total knee arthroplasty (TKA) spent less time in the hospital and were significantly less likely to need to go to a rehabilitation center after discharge, a recent study found.
Patients given liposomal bupivacaine spent a half-day less in the hospital than those administered routine, opioid-based pain medications, according to the review of patient records by researchers at Philadelphia College of